
POET Technologies Reports First Quarter 2025 Financial Results
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) — POET Technologies Inc. ('POET' or the 'Company') (TSX Venture: PTK; NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today reported its unaudited condensed consolidated financial results for the first quarter ended March 31, 2025. The Company's financial results as well as the Management Discussion and Analysis have been filed on SEDAR+. All financial figures are in United States dollars ('USD') unless otherwise indicated.
Management Commentary:
'In the first quarter of 2025, we continued to build momentum across multiple fronts—technology innovation, commercial progress, strategic partnerships and production capacity - positioning the company for accelerated revenue growth in the second half of the year,' said Dr. Suresh Venkatesan, Chairman & CEO of POET Technologies. 'The transition out of SPX in China into Malaysia was a timely and energizing event for the Company. Opening a 10,000 square foot clean room filled with wafer-level production tools at our partner, Globetronics, was the indispensable next step to accepting volume orders from AI and cloud data center customers. As we look ahead, we are building on the strong foundation of innovative products introduced at OFC, and the reaction of customers and partners, reinforces our conviction that POET is on the cusp of a meaningful revenue inflection later this year.'
Notable Business Highlights:
Non-IFRS Financial Summary
The Company reported non-recurring engineering ('NRE') and product revenue of $166,760 in the first quarter of 2025 compared to $8,710 for the same period in 2024 and $29,032 in the fourth quarter of 2024. Historically, the Company provided NRE services to multiple customers for unique projects that are being addressed utilizing the capabilities of the POET Optical Interposer. The Company only had small product revenue in Q1 2025.
The Company reported a net income of $6.3 million, or $0.08 per share, in the first quarter of 2025 compared with a net loss of $5.7 million, or ($0.13) per share, for the same period in 2024 and a net loss of $30.2 million, or ($0.50) per share, in the fourth quarter of 2024. The net income in the first quarter of 2025 included research and development costs of $4.3 million compared to $1.9 million for the same period in 2024 and $3.4 million in the fourth quarter of 2024. Fluctuations in R&D for a Company of this size and this stage of growth is expected on a period-over-period basis as the Company transitions from technology development to product development.
The largest component of the Company's income was from the non-cash gain in fair value adjustment to derivative warrant liability of $15.4 million in the first quarter of 2025, compared to loss of $630,000 in the same period in 2024 and a loss of $12.4 million in the fourth quarter of 2024. This non-cash item relates to warrants issued in a foreign currency and is periodically remeasured.
Other non-cash expenses in the first quarter of 2025 included stock-based compensation of $0.8 million and depreciation and amortization of $0.7 million. Non-cash stock-based compensation and depreciation and amortization in the same period of 2024 were $0.9 million and $0.5 million, respectively. Fourth quarter 2024 stock-based compensation and depreciation and amortization were $1.4 million and $0.5 million, respectively. The Company had non-cash finance costs of $33,000 in the first quarter of 2025 compared to non-cash finance costs of $20,000 in the first quarter of 2024 and non-cash costs of $32,000 in the fourth quarter of 2024.
The Company recognized other income, including interest of $528,000 in the first quarter of 2025, compared to $52,000 in the same period in 2024 and $511,000 in the fourth quarter of 2024.
During the fourth quarter of 2024, the Company acquired the remaining 24.8% interest of SPX from SAIC. The acquisition of this interest resulted in a non-cash loss to the Company of $6,852,687. There was no impact of the acquisition transaction in the first quarter of 2025.
Cash flow from operating activities in the first quarter of 2025 was ($8.9) million compared to ($4.6) million in the first quarter of 2024 and ($8.7) million in the fourth quarter of 2024.
Summary of Financial Performance
The following is a summary of the Company's operations over the five quarters ending March 31, 2025. This information should be read in conjunction with the Company's financial statements filed on Sedar+ on May 14, 2025.
About POET Technologies Inc.
POET is a design and development company offering high-speed optical modules, optical engines and light source products to the artificial intelligence systems market and to hyperscale data centers. POET's photonic integration solutions are based on the POET Optical Interposer™, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using advanced wafer-level semiconductor manufacturing techniques. POET's Optical Interposer-based products are lower cost, consume less power than comparable products, are smaller in size and are readily scalable to high production volumes. In addition to providing high-speed (800G, 1.6T and above) optical engines and optical modules for AI clusters and hyperscale data centers, POET has designed and produced novel light source products for chip-to-chip data communication within and between AI servers, the next frontier for solving bandwidth and latency problems in AI systems. POET's Optical Interposer platform also solves device integration challenges in 5G networks, machine-to-machine communication, self-contained 'Edge' computing applications and sensing applications, such as LIDAR systems for autonomous vehicles. POET is headquartered in Toronto, Canada, with operations in Allentown, PA, Shenzhen, China, and Singapore. More information about POET is available on our website at
www.poet-technologies.com
.
Forward-Looking Statements
This news release contains 'forward-looking information' (within the meaning of applicable Canadian securities laws) and 'forward-looking statements' (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as 'anticipate', 'believe', 'expect', 'plan', 'intend', 'potential', 'estimate', 'propose', 'project', 'outlook', 'foresee' or similar words suggesting future outcomes or statements regarding any potential outcome. Such statements include the Company's expectations with respect to its move of production capacity from China to Malaysia, the ability of its partners to install and operate production equipment, the reaction of customers and partners to the Company's product offerings, the success of the Company's product development efforts, the performance of its products, the expected results of its operations, meeting revenue targets, and the expectation of continued success in the financing efforts, the capability, functionality, performance and cost of the Company's technology as well as the market acceptance, inclusion and timing of the Company's technology in current and future products and expectations for approval of proposals at the Company's annual meeting of shareholders.
Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Assumptions have been made regarding, among other things, management's expectations regarding its move of production capacity from China to Malaysia, the ability of its partner to meet production expectations, the reaction of customers and partners to the Company's product offerings, the success and timing for completion of its development efforts, the introduction of new products, financing activities, future growth, recruitment of personnel, opening of offices, the form and potential of its joint venture, plans for and completion of projects by the Company's consultants, contractors and partners, availability of capital, and the necessity to incur capital and other expenditures. Actual results could differ materially due to a number of factors, including, without limitation, the failure to achieve high volume production in Malaysia on time, the failure of its products to meet performance requirements or to be produced in Malaysia on time and budget, the lack of sales in its products, once released, operational risks in the completion of the Company's anticipated projects, risks affecting the Company's ability to execute projects, the ability of the Company to generate sales for its products, the ability to attract key personnel, the ability to raise additional capital and the agreement by shareholders to approve proposals put forth by the Company at shareholders' meetings. Although the Company believes that the expectations reflected in the forward-looking information or statements are reasonable, prospective investors in the Company's securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise this forward-looking information and statements except as required by law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2 - Tel: 416-368-9411 - Fax: 416-322-5075
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Stellantis Publishes Agenda for 2025 Extraordinary General Meeting of Shareholders
Stellantis Publishes Agenda for 2025 Extraordinary General Meeting of Shareholders AMSTERDAM, June 5, 2025 – Stellantis N.V. today announced the publication of the agenda and explanatory notes for its 2025 Extraordinary General Meeting of Shareholders (EGM), which is scheduled to take place on July 18, 2025, in Amsterdam. As previously announced, the EGM will resolve the proposed appointment of Mr. Antonio Filosa as an executive director of the Company. Antonio Filosa is a veteran of the Company with a proven track record of hands-on success spanning over 25 years in the automotive industry. He has led Stellantis in both North and South America as well as in Global Quality. During his time as Chief Operating Officer of South America, the FIAT brand gained a market-leading position, along with significant growth in the Peugeot, Citroën, Ram, and Jeep® brands. As a result, Stellantis became a clear industry leader in the region. He led the startup of the Pernambuco plant, one of South America's largest automotive hubs, and launched Jeep® in Brazil, which became the brand's leading market outside of the United States. As CEO of Jeep®, Antonio Filosa expanded the brand's global presence, including in Europe, thanks to very popular products such as the Jeep® Avenger. Since his appointment to the role of Chief Operating Officer, Americas in December 2024, he has initiated the strengthening of U.S. operations, including significantly reducing excessive dealer inventory, reorganizing the leadership team, driving the process of introducing new products and powertrains, and increasing dialogue to improve relationships with dealers, unions and suppliers. The official notice of the EGM, along with explanatory notes and related materials and voting instructions, is now available in the Investors section of the Stellantis corporate website at Shareholders may also request a printed copy of these materials, using the contact information provided below. # # #Stellantis N.V. (NYSE: STLA / Euronext Milan: STLAM / Euronext Paris: STLAP) is a leading global automaker, dedicated to giving its customers the freedom to choose the way they move, embracing the latest technologies and creating value for all its stakeholders. Its unique portfolio of iconic and innovative brands includes Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, FIAT, Jeep®, Lancia, Maserati, Opel, Peugeot, Ram, Vauxhall, Free2move and Leasys. For more information, visit @Stellantis Stellantis Stellantis Stellantis For more information, contact:Fernão SILVEIRA +31 6 43 25 43 41 – ROUSSEL +33 6 87 77 41 82 – Attachment EN-20250605-Stellantis-2025-EGM-AgendaSign in to access your portfolio
Yahoo
18 minutes ago
- Yahoo
Lumination Hive Announces Launch of New Book on Resilient Leadership by Founder Brenna Davis
Portland, OR , June 05, 2025 (GLOBE NEWSWIRE) -- Lumination Hive, a leadership and strategy firm focused on resilient and regenerative business practices, today announced the upcoming release of Leading Through Fire: Resilient Leadership for People, Planet, and the Future. The book, authored by Lumination Hive founder and CEO Brenna Davis, will be released on June 24, DavisDavis currently serves as CEO of one of the nation's leading mission-driven companies, structured as a Perpetual Purpose Trust (PPT). She founded Lumination Hive to expand access to leadership tools that support systemic change, inclusive governance, and long-term impact across sectors. Leading Through Fire is designed to support leaders facing volatility across industries—from climate disruption and economic uncertainty to organizational change and social fragmentation. The book provides a field-tested framework for building adaptive, principle-driven leadership in challenging environments. Organized into nine concise chapters, the book includes: Practical reflections designed for leaders navigating real-time complexity Tools for aligning daily actions with long-term organizational purpose Strategies to build momentum and avoid burnout during extended uncertainty Frameworks for creating resilient systems rooted in trust and inclusivity Guidance on leading with clarity and compassion in times of disruption 'This book was developed in response to what organizations are navigating right now—constant change, rising expectations, and a need for leadership that balances decisiveness with care,' said Brenna Davis, founder of Lumination Hive and CEO of a Perpetual Purpose Trust–structured company. 'The content provides structure and clarity without oversimplifying the complexity of this moment.' Kevin Wilhelm, founder of Sustainable Business Consulting and bestselling author, endorsed the book:'Brenna's book has found a way to cut through to the heart of so many of our problems, by providing a blueprint for all leaders, and aspiring ones. She shows how best to lead to best achieve desired results with compassion, resilience and grace.' The book draws on more than two decades of experience in regenerative business strategy, stakeholder governance, and mission-aligned leadership. It reflects Lumination Hive's mission to help leaders and organizations navigate complexity, grow with integrity, and create lasting impact. Lumination Hive provides leadership consulting, executive coaching, keynote speaking, and publications for boards, founders, and purpose-driven teams. The firm supports organizations seeking alternatives to extractive business models by building durable cultures of trust, accountability, and regeneration. Leading Through Fire will be released on June 24, 2025. Early readers can join the waitlist now to receive updates and exclusive launch access. Join the waitlist and learn more at: Leading Through Fire: Resilient Leadership for People, Planet, and the Future Cover About Lumination Hive, LLC Lumination Hive exists to support leaders and organizations who are here to do the deep work of transformation, of integrity, of building the future. We are a strategy and leadership firm for the next economy, partnering with CEOs, founders, boards, and teams ready to lead with clarity and build with purpose. Our work lives at the intersection of regenerative leadership, alternative governance, and long-term strategy—because we believe the future belongs to those who can hold complexity without losing their center. Founded by Brenna Davis—CEO, environmental scientist, board leader, and author—Lumination Hive blends decades of real-world experience with frameworks that are fresh, practical, and deeply human. Press inquiries Lumination Hive, LLC Brenna Davis brennadavis@ 2069790251
Yahoo
22 minutes ago
- Yahoo
Psychedelic Science 2025 Announces 'Conscious Capitalism Workshop' Featuring 'Heroic' and 'Microdose' Pitch Opportunities for Visionary Startups
Innovators, Visionaries, and VCs Will Unite for an Interactive, High-Impact, Shark-Tank-Like Session Empowering the Next Generation of Psychedelic Entrepreneurs DENVER, June 05, 2025 (GLOBE NEWSWIRE) -- Psychedelic Science 2025 (PS2025), the world's leading conference on psychedelic research, medicine, policy, and culture hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), today announced the addition of the Conscious Capitalism Workshop, a dynamic event blending education, investment insight, and two levels of live founder pitches: the Heroic Pitch and the Microdose Pitch. This high-energy, interactive session, taking place on Monday, June 16, 2025, from 2:30 PM to 6:00 PM at the Colorado Convention Center, offers a rare behind-the-scenes look at the values-aligned startup journey in the psychedelic ecosystem. While informally referred to as the 'Shark Tank' of PS2025, the session prioritizes mentorship over competition and integration over extraction. Attendees can hear first-hand from the 'Sharks' on how they evaluate companies and what they consider when making investment decisions. Workshop Format VC 101 Roundtable: A candid conversation led by Lewis Goldberg, Partner at KCSA Strategic Communications, exploring how psychedelic investing works—covering capital strategy, founder readiness, and ethical funding decisions. The Heroic Pitch: Select early-stage companies will deliver 10-minute pitches, followed by real-time investor feedback and shared insights. The Microdose Pitch: In this rapid-fire format, any attendee can apply to deliver a concise 2–3 minute pitch to showcase their vision. Networking Reception: The session concludes with cocktails and open networking to foster connection and collaboration. Featured Conscious Capitalists Simeon Schnapper, Managing Partner, JLS Fund Shelby Clark, Partner, Lionheart Ventures; Founder, Turo Amy Emerson, Former CEO, Lykos Therapeutics Tim Regan, Analyst, Water Tower Research These industry leaders bring deep experience in venture capital, biotech, therapeutics, and psychedelic infrastructure—and they are here not to judge, but to uplift and empower the next wave of impact entrepreneurs. A Call to Action 'This workshop is more than timely—it's essential. At a time when our nation faces an unprecedented mental health crisis, we can't wait for institutional systems to catch up. The real breakthroughs—from technology to biotech—have always come from bold founders building from the ground up. Just look at the history—Intel, Meta, Moderna, Genentech. These weren't top-down solutions. They were startups led by visionaries and backed by investors who saw the future before the market did. The PS2025 Conscious Capitalism Workshop is about giving today's psychedelic pioneers the tools, insight, and access to become tomorrow's impact giants.'— Lewis Goldberg, KCSA Partner and Moderator of the Conscious Capitalism Workshop Apply for the Microdose Pitch In a rare opportunity, applicants not selected for the Heroic Pitch can apply to participate in the Microdose Pitch—a rapid-fire, 2–3 minute live pitch in front of leading psychedelic investors and influencers. This will be a first come, first served opportunity. No slides. No pressure. Just your story, your idea, and your three minutes. To apply: Email your name, company, and a short explanation of your pitch to PS2025@ Monday, June 10, 2025, by 5:00 p.m. ETSpots are limited. The value of this exposure is immeasurable. More Than Capital — A Movement for Integration The Conscious Capitalism Workshop reflects the overarching Psychedelic Science 2025 theme of The Integration, bridging science, spirituality, innovation, and investment. As psychedelic medicine evolves into a regulated industry, how we build it—and who we empower to lead—matters more than ever. Visit to view full programming, register for workshops, and explore hotel and travel options. All Business workshops are included in the Business level registration and are available as add-ons on a limited basis. About Psychedelic SciencePsychedelic Science 2025 (PS2025), hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), is the world's leading psychedelic conference. Returning to the Colorado Convention Center in Denver from June 16-20, 2025, this five-day event brings together a global community of scientists, therapists, policymakers, cultural leaders, and advocates to explore the forefront of psychedelic research, therapy, and culture. Facilitated by Superfly, known for producing iconic events such as Bonnaroo and Outside Lands, PS2025 will feature expert speakers; hands-on workshops; community events with art, music, and mindfulness activities; and scholarship opportunities to support broad participation. Since its inception in 2010, the Psychedelic Science conference series has fostered knowledge-sharing, collaboration, and community-building within the psychedelic ecosystem. Join thousands of attendees as we explore the transformative potential of psychedelics and shape the future of mental health, policy, and cultural understanding. For more information and registration details, visit and follow us on X, Instagram, LinkedIn, and Facebook. ABOUT MAPSFounded in 1986, MAPS is a 501(c)(3) nonprofit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS' conference flagship, Psychedelic Science, has been the leading convening of the psychedelic community since 2010. MAPS incubated Lykos Therapeutics, a drug-development public benefit company, and the Zendo Project, a leader in psychedelic harm reduction. Since MAPS was founded, philanthropic donors and grantors have given more than $150 million to advance research, change drug policy, and evolve education in the field of psychedelics. CONTACTmedia@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data